| 1 |
Youssef DM, El-Shal AS, Elbehidy RM, Fouda MA, Shalaby SM, El Hawy LL, Elsadek AF, Neemat-Allah MAA, Ramadan SM, Gohary A, Arab F, Alsharkawy M, Tolba SAR, Abdelsalam MM, Amin EK, Gehad MH. Hepatitis B Immunization Status in Children with Chronic Kidney Disease: Experience at a Single Center, Egypt. J Clin Med 2023;12. [PMID: 36902652 DOI: 10.3390/jcm12051864] [Reference Citation Analysis]
|
| 2 |
Duarte R, Soares R, Lu I, Ferrer F, Gama P, Gonçalves H, Lopes K, Sofia F, Cortes C, Vila Lobos A. Prevalence of SARS-CoV-2 Cellular and Humoral Immunity Amongst Patients on Dialysis After the First Vaccination Campaign. EMJ Nephrol 2022. [DOI: 10.33590/emjnephrol/10023287] [Reference Citation Analysis]
|
| 3 |
Bekele Y, Berzofsky JA, Chiodi F. Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals. Vaccines (Basel) 2021;9:1484. [PMID: 34960230 DOI: 10.3390/vaccines9121484] [Reference Citation Analysis]
|
| 4 |
Duarte R, Roldão M, Figueiredo C, Luz I, Ferrer F, Gonçalves H, Sofia F, Lopes K. Humoral response to BNT162b2 mRNA COVID-19 vaccine in peritoneal and hemodialysis patients: A comparative study. Ther Apher Dial 2021. [PMID: 34837463 DOI: 10.1111/1744-9987.13766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Speer C, Göth D, Benning L, Buylaert M, Schaier M, Grenz J, Nusshag C, Kälble F, Kreysing M, Reichel P, Töllner M, Hidmark A, Ponath G, Schnitzler P, Zeier M, Süsal C, Morath C, Klein K. Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2. Clin J Am Soc Nephrol 2021;16:1073-82. [PMID: 34031181 DOI: 10.2215/CJN.03700321] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 36.5] [Reference Citation Analysis]
|
| 6 |
Feng Y, Wang J, Shao Z, Chen Z, Yao T, Dong S, Wu Y, Shi X, Shi J, Liu G, Bai J, Guo H, Liu H, Wu X, Liu L, Song X, Zhu J, Wang S, Liang X. Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regression. Hum Vaccin Immunother 2021;17:3214-20. [PMID: 33989106 DOI: 10.1080/21645515.2021.1895603] [Reference Citation Analysis]
|
| 7 |
Arora A, Kumar A, Prasad N, Duseja A, Acharya SK, Agarwal SK, Aggarwal R, Anand AC, Bhalla AK, Choudhary NS, Chawla YK, Dhiman RK, Dixit VK, Gopalakrishnan N, Gupta A, Hegde UN, Jasuja S, Jha V, Kher V, Kumar A, Madan K, Maiwall R, Mathur RP, Nayak SL, Pandey G, Pandey R, Puri P, Rai RR, Raju SB, Rana DS, Rao PN, Rathi M, Saraswat VA, Saxena S, Shalimar, Sharma P, Singh SP, Singal AK, Soin AS, Taneja S, Varughese S. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease. J Clin Exp Hepatol 2021;11:354-86. [PMID: 33994718 DOI: 10.1016/j.jceh.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Bechini A, Bonanni P, Grazzini M, Paolini D, Arcangeli G, Mucci N, Bini C, Tiscione E, Zanella B, Boccalini S. Need to take special care of non-responders to hepatitis B vaccination among health-care workers, students and chronic patients. Hum Vaccin Immunother 2021;17:580-2. [PMID: 33270480 DOI: 10.1080/21645515.2020.1810495] [Reference Citation Analysis]
|
| 9 |
Bayart JL, Favresse J, Stoefs A, Closset M, Roy T, Fillée C, Rodriguez-Villalobos H, Kabamba-Mukadi B, Gruson D. Biotin interferences: Have we neglected the impact on serological markers? Clin Chim Acta 2020;503:107-12. [PMID: 31978405 DOI: 10.1016/j.cca.2020.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 10 |
Kengibe PY, Makulo JR, Nlandu YM, Lepira FB, Sumaili EK, Bukabau JB, Mbendi CN, Ahuka SM, Tshimpi AW, Ngoma PK, Mangani NN, Mbendi SN. Response to single dose hepatitis B vaccine in Congolese non-HIV hemodialysis patients: a prospective observational study. Pan Afr Med J 2019;34:122. [PMID: 33708291 DOI: 10.11604/pamj.2019.34.122.19603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Hatami H, Prof. of Infectious and Tropical Diseases and Master of Public Health (MPH), Dept. of Public Health, School of Health and Environmental and Occupational Hazard Control Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Movafagh P, Ramezankhani A, Master of Public Health (MPH), Dept. of Public Health, School of Public Health and Immunity, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Prof. of Health Education & Health Promotion, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.. An Investigation of the Immune Response to Hepatitis B Vaccination in Hemodialysis Patients at Dialysis Centers of Tehran (2016). JOHE 2019;8:171-175. [DOI: 10.29252/johe.8.4.171] [Reference Citation Analysis]
|
| 12 |
Saco TV, Strauss AT, Ledford DK. Hepatitis B vaccine nonresponders: Possible mechanisms and solutions. Ann Allergy Asthma Immunol. 2018;121:320-327. [PMID: 29567355 DOI: 10.1016/j.anai.2018.03.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 13 |
Van Damme P, Ward JW, Shouval D, Zanetti A. Hepatitis B Vaccines. Plotkin's Vaccines 2018. [DOI: 10.1016/b978-0-323-35761-6.00025-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 14 |
Feng Y, Shi X, Shi J, Gao L, Liu G, Cheng Y, Pan M, Li C, Wang J, Guo X, Zhang Y, Liang X, Wang S. Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial. Expert Rev Vaccines 2017;16:1045-52. [PMID: 28803502 DOI: 10.1080/14760584.2017.1367667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 15 |
Asan A, Demirhan H, Sorkun HÇ, Özkan S, Aydın M, Akın D, Tatar B, Çatak B, Şener A, Köse Ş. Factors affecting responsiveness to hepatitis B immunization in dialysis patients. Int Urol Nephrol 2017;49:1845-50. [PMID: 28620716 DOI: 10.1007/s11255-017-1616-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 16 |
Isnard Bagnis C, Couchoud C, Bowens M, Sarraj A, Deray G, Tourret J, Cacoub P, Tezenas du Montcel S. Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France. Liver Int 2017;37:820-6. [PMID: 28107607 DOI: 10.1111/liv.13367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Kauke T, Link M, Rentsch M, Stangl M, Guba M, Andrassy J, Werner J, Meiser B, Fischereder M, Habicht A. Antibody response to HBV vaccination on dialysis does not correlate with the development of deNovo anti-HLA antibodies after renal transplantation. Transpl Immunol 2017;42:5-8. [PMID: 28457920 DOI: 10.1016/j.trim.2017.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
